跳至主要内容
临床试验/ISRCTN13199265
ISRCTN13199265已完成未知

The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial

niversity clinical center of Republika Srpska0 个研究点目标入组 66 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
66

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665453/ (added 20/10/2021)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Polycystic Ovary Syndrome, diagnosed in accordance with Rotterdam Consensus Conference Criteria 2003
  • 2. Age 18 - 40 years

排除标准

  • 1. Significant liver or renal impairment
  • 2. Other hormonal dysfunction (hypothalamic, pituitary, thyroidal or adrenal causes for the clinical signs)
  • 3. History of drug and alcohol abuse
  • 4. History of breast and uterine cancer
  • 5. Diagnosis of diabetes mellitus
  • 6. Use of drugs able to interfere with gluco-insulinaemic metabolism for at least three months prior to entering the study

研究者

发起方
niversity clinical center of Republika Srpska

相似试验

The effect of metformin and myoinositol in women... | 临床试验